Hectorol Will Drive Genzyme’s Renal Business; “Share Of Voice” To Jump

Genzyme expects its acquisition of Bone Care International will drive sales of both Hectorol (doxercalciferol) and Renagel (sevelamer) through the strength of joint promotions

More from Archive

More from Pink Sheet